| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |